Closing Bell: Fennec Pharmaceuticals Inc up on Wednesday (FRX)
Today, Fennec Pharmaceuticals Inc stock opened at $9.21 and closed at $9.04. It traded at a low of $9.04 to a high of $9.21.
Shares advanced 0.22% from the previous day's close of $9.02.
Today across North America, the TSX Composite closed -0.76% at 22639.57, the S&P 500 closed -0.16% at 5555.74, the Dow Jones Industrial Average closed -0.14% at 40358.09 and the Nasdaq Composite closed -0.06% at 17997.35.
Fennec Pharmaceuticals Inc traded under FRX on the Toronto Stock Exchange (TSX).
Trading volume was 500 on 4 total trades, with an average volume of 1,360 over the last 5 days.
Trading across the entire TSX saw 1,249 price advancers against 3,959 declines and 110 unchanged.
During the prior 52 weeks, FRX.TO has traded as high as $15.43 (December 28,2023) and low as $7.80 (July 05,2024). Moreover, the shares have reduced -19.79% in the last year, while in 2024, they have shrunken -40.37%.
Following today's trading, Fennec Pharmaceuticals Inc has a market capitalization of $246.44 million on a float of 27,322 shares outstanding. Its annual EPS is $0.04.
Fennec Pharmaceuticals Inc is a None company headquartered in Research Triangle Park, USA.
Fennec Pharmaceuticals Inc is holding an average recommendation of "Strong Buy" from 6.00 analysts according to Zacks. From those 6 analysts, 6 have buy ratings.
AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..
